MHRA consult over naproxen from POM to P

The Medicines and Healthcare products Regulatory Agency (MHRA) is consulting on changing the classification of naproxen 250mg from a prescription only medicine to pharmacy only.

Dysmenorrhoea (period pain) is a common, chronic, recurring condition, which affects a significant proportion of women of reproductive age. Many of these women rely on OTC analgesics to manage this pain.

Dysmenorrhoea responds well to treatment with non-steroidal anti-inflammatory drugs (NSAIDs) because these products inhibit the production of prostaglandins which play a part in the smooth muscle contractility of the womb.

Currently, ibuprofen is the only available non-prescription NSAID.

The MHRA believes that naproxen would be a good alternative to ibuprofen and pharmacists have demonstrated their ability to recommend OTC treatments for dysmenorrhoea.

The consultation documents may be found on the MHRA website

MIMS links
Printable patient fact sheet on dysmenorrhoea


Pain and fever

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us: